Publications by authors named "Nicolas Dubuisson"

Claim this Profile
D
Describing phenotypes in FSHD: an update of the comprehensive clinical evaluation form.
Giulia Ricci, Francesca Torri, Lucia Ruggiero, Liliana Vercelli, Giulio Gadaleta, Nicolas Dubuisson

Neurol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy.
Michel Abou-Samra, Nicolas Dubuisson, Alice Marino, Camille M Selvais, Versele Romain

Antioxidants (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital Myasthenic Syndromes in Belgium: Genetic and Clinical Characterization of Pediatric and Adult Patients.
Nathalie Smeets, Alexander Gheldof, Bart Dequeker, Margaux Poleur, Sofia Maldonado Slootjes, Nicolas Dubuisson

Pediatr Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Sarcopenia: Exploring AdipoRon in Aging Skeletal Muscle as a Healthspan-Extending Shield.
Camille M Selvais, Maria A Davis-López de Carrizosa, Romain Versele, Nicolas Dubuisson, Laurence Noel

Antioxidants (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measures.
Bram De Wel, Louise Iterbeke, Lotte Huysmans, Ronald Peeters, Veerle Goosens, Nicolas Dubuisson

Eur J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Implementing new technologies for neuromuscular disorders.
Nicolas Dubuisson, Kristl Claeys, Benedikt Schoser

Front Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle.
Nicolas Dubuisson, Romain Versele, Maria A Davis-López de Carrizosa, Camille M Selvais, Laurence Noel

Cells· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AdipoRon enhances healthspan in middle-aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers.
Camille M Selvais, María A Davis-López de Carrizosa, Maxime Nachit, Romain Versele, Nicolas Dubuisson

J Cachexia Sarcopenia Muscle· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy.
Nicolas Dubuisson, Romain Versele, Chloé Planchon, Camille M Selvais, Laurence Noel

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy.
Nicolas Dubuisson, María A Davis-López de Carrizosa, Romain Versele, Camille M Selvais, Laurence Noel

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?
Antoine Guilmot, Sofia Maldonado Slootjes, Véronique Bissay, Nicolas Dubuisson, Clémence de Broglie

Acta Neurol Belg· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Walking down Skeletal Muscle Lane: From Inflammasome to Disease.
Nicolas Dubuisson, Romain Versele, María A Davis-López de Carrizosa, Camille M Selvais, Sonia M Brichard

Cells· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation.
Danique Beijer, Hong Joo Kim, Lin Guo, Kevin O'Donovan, Inès Mademan, Nicolas Dubuisson

JCI Insight· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulin-induced aseptic meningitis in a patient with Miller Fisher syndrome.
Sofia Maldonado Slootjes, Antoine Guilmot, Nicolas Dubuisson, Vincent van Pesch, Souraya Elsankari

Acta Neurol Belg· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?
Michel Abou-Samra, Camille M Selvais, Nicolas Dubuisson, Sonia M Brichard

Int J Mol Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion criteria used in trials of people with progressive multiple sclerosis.
Nicolas Dubuisson, Monica Marta, Sharmilee Gnanapavan, Benjamin Turner, David Baker

Mult Scler· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies.
Markus Axelsson, Nicolas Dubuisson, Lenka Novakova, Clas Malmeström, Gavin Giovannoni

Acta Neurol Scand· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab depletion failure can occur in multiple sclerosis.
Nicolas Dubuisson, David Baker, Angray S Kang, Gareth Pryce, Monica Marta

Immunology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.
Bryan Ceronie, Benjamin M Jacobs, David Baker, Nicolas Dubuisson, Zhifeng Mao

J Neurol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease modification in advanced MS: Focus on upper limb function.
Nicolas Dubuisson, David Baker, Alison Thomson, Monica Marta, Sharmilee Gnanapavan

Mult Scler· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cramp-fasciculation syndrome associated with monofocal motor neuropathy.
Nicolas J Dubuisson, Vincent Van Pesch, Peter Y K Van Den Bergh

Muscle Nerve· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Science is 1% inspiration and 99% biomarkers.
Nicolas Dubuisson, Fabiola Puentes, Gavin Giovannoni, Sharmilee Gnanapavan

Mult Scler· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an environmentally-friendly and affordable cardboard 9-hole peg test.
Nicolas Dubuisson, Angelika Bauer, Mark Buckley, Rich Gilbert, Adam Paterson

Mult Scler Relat Disord· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis